ÂÜÀòÂÒÂ×

Joerg Moeller, MD, is a strategic executive with extensive experience in global research and development within the pharmaceutical industry. Currently serving as a Member of the Board of Directors at Secura Bio, Inc., Joerg previously held the position of Corporate EVP, Head of Global Research and Development at LEO Pharma. Joerg's tenure at Bayer spanned nearly two decades, where responsibilities included leading global research and development activities and overseeing significant product developments resulting in first-in-class approvals. Notable achievements include directing the clinical development of key drugs such as Rivaroxaban (Xarelto) and Aflibercept (Eylea). Joerg holds an MD from Ruhr University Bochum, alongside executive education credentials from IESE Business School and the Center for Creative Leadership.